Regulatory News:
Groupe Berkem (the "Group") (Paris:ALKEM), a leading player in bio-based chemicals (ISIN code: FR00140069V2 Ticker: ALKEM), announces today its 2024 financial calendar.
Event | Date * | ||
2023 Full-Year Revenue | January 31, 2024 | ||
2023 Full-Year Results | April 29, 2024 | ||
2024 First-Quarter Revenue | April 29, 2024 | ||
Annual General Meeting | June 25, 2024 | ||
2024 First-Half Revenue | July 25, 2024 | ||
2024 First-Half Results | September 26, 2024 | ||
2024 Third-Quarter Revenue | October 24, 2024 |
* this information is subject to modification.
ABOUT GROUPE BERKEM
Founded in 1993 by Olivier Fahy, Chairman and Chief Executive Officer, Groupe Berkem is a leading force in the bio-based chemicals market. Its mission is to advance the environmental transition of companies producing the chemicals used in everyday life (Construction Materials, Health, Beauty Nutrition, Hygiene Protection, and Industry). By harnessing its expertise in both plant extraction and innovative formulations, Groupe Berkem has developed bio-based boosters-unique high-quality bio-based solutions augmenting the performance of synthetic molecules. Groupe Berkem achieved revenue of €51.8 million in 2022. The Group has almost 200 employees working at its head office (Blanquefort, Gironde) and 4 production facilities in Gardonne (Dordogne), La Teste-de-Buch (Gironde), Chartres (Eure-et-Loir) and Tonneins (Lot-et-Garonne).
Groupe Berkem has been listed on Euronext Growth Paris since December 2021 (ISIN code: FR00140069V2 ALKEM).
www.groupeberkem.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240110799902/en/
Contacts:
Groupe Berkem
Olivier Fahy, Chief Executive Officer
Anthony Labrugnas, Chief Financial Officer
Tel.: +33 (0)5 64 31 06 60
investisseurs@berkem.com
NewCap
Investor Relations
Mathilde Bohin Nicolas Fossiez
Tel.: +33 (0)1 44 71 94 94
Berkem@newcap.eu
NewCap
Media Relations
Nicolas Merigeau/ Antoine Pacquier
Tel.: +33 (0)1 44 71 94 94
Berkem@newcap.eu